
The panel considers how AI and automation could reshape peptide method development, and why scientific judgment will remain essential.
BrightSpec's platform achieved LODs of 3 ppm for EG and 60 ppm for DEG in PEG-400. Linearity was strong and repeatability remained under 4%.





